News & Analysis as of August 30, 2025

Telemedicine

+ Follow

Read guidance, analysis, and updates on the myriad issues arising from the global response to the COVID-19 pandemic. Updated hourly every day, the insights published here are written by leading lawyers and law firms helping to make sense of insurance, employment, tax, securities, M&A, risk management, and every other consideration touched by this crisis. Follow the channel for a daily email brief of the latest and best updates. less -

The Health Record - Healthcare Law Insights, V 2, Issue 6, June 2025

Spilman Thomas & Battle, PLLC on 6/9/2025

Welcome to our sixth issue of 2025 of The Health Record -- our healthcare law insights e-newsletter. In this edition, we look at the impact of supply chain and tariff issues on the industry, the veto of Florida's...more

Telehealth Cliff Averted, for Now (But September is Six Months Away)

Epstein Becker & Green on 3/26/2025

The potential plunge off the telehealth cliff that we warned you about in our March 3, 2025, blog post has been averted, for now....more

Medicare Telehealth Waivers Extended Through September 2025

Baker Donelson on 3/21/2025

On March 15, 2025, Congress passed and President Trump signed into law a Continuing Resolution that temporarily extends certain critical programs and appropriations through September 30, 2025. The legislation, titled the...more

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

Polsinelli on 3/18/2025

On March 15, 2025, President Trump signed a continuing resolution to avert a government shutdown, which included a critical six-month extension of Medicare telehealth flexibilities through September 30, 2025. This six-month...more

DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain

McDermott+ on 1/20/2025

On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for Telemedicine and Limited State Telemedicine Registrations. This proposed rule would establish three...more

Some COVID-Era Medicare Telehealth Waivers Extended through March 31

Rivkin Radler LLP on 1/17/2025

The American Relief Act, 2025, signed into law on December 21, included a short-term extension of certain telehealth waivers that went into effect in the early days of the COVID-19 Public Health Emergency. These waivers, for...more

UPDATE: Telehealth “Cliff” Pushed Back until April 1, 2025

Bradley Arant Boult Cummings LLP on 1/6/2025

Congress narrowly avoided hurdling off the telehealth “cliff” Bradley previously reported on in this post with the passing of the American Relief Act, 2025 on December 21, 2024...more

Congress Extends Telehealth Flexibilities for Two More Years

Sheppard Mullin Richter & Hampton LLP on 12/19/2024

With only two weeks remaining in the year, Congress is considering a government funding deal (the “Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025” or the “Bill”) that includes a...more

Update: Telehealth “Cliff” Looming at End of 2024

Bradley Arant Boult Cummings LLP on 12/18/2024

As 2024 comes to a close, the telehealth space continues to be uncharted territory. When the COVID-19 pandemic began, the ability to deliver telehealth expanded as providers sought to provide quality care unrestricted by...more

Is the End Near? Medicare Telehealth Flexibilities Set to Expire at the End of the Year

Dinsmore & Shohl LLP on 12/13/2024

The temporary telehealth flexibilities that Medicare patients and providers have become accustomed to since the COVID-19 pandemic are set to expire December 31, 2024. The Consolidated Appropriations Act of 2023 extended many...more

DEA/HHS Telemedicine Prescribing of Controlled Substances Extension

Cooley LLP on 11/22/2024

On November 15, 2024, the US Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) jointly issued a temporary rule, which extends the current flexibilities relating to prescribing controlled...more

DEA Further Extends Telemedicine Prescribing Flexibilities through December 2025

Dinsmore & Shohl LLP on 11/21/2024

The Drug Enforcement Administration (DEA) is once again extending telemedicine prescribing flexibilities for controlled substances. This latest extension, which is now the third extension of such flexibilities originally...more

Medicare Telehealth Reimbursement Update

Tucker Arensberg, P.C. on 11/21/2024

Our Introduction to Telehealth, Technology and Federal Enforcement chapter was published in the Thomson Reuters 2025 Health Law Handbook. It reviewed a number of telehealth Medicare revisions, both permanent and temporary,...more

DEA and HHS Extend COVID-19 Telemedicine Prescribing Flexibilities Again

Wilson Sonsini Goodrich & Rosati on 11/20/2024

The federal Drug Enforcement Agency (DEA) and the U.S. Department of Health and Human Services (HHS) have extended COVID-19 telemedicine flexibilities for prescribing controlled substances. Until December 31, 2025, a...more

DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025

McDermott Will & Schulte on 11/19/2024

The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The flexibilities were...more

DEA Extends Telehealth Lifeline for Patients

Robinson+Cole Health Law Diagnosis on 11/18/2024

On November 15, 2024, the Drug Enforcement Administration (DEA) and the Department of Health & Human Services (HHS) jointly announced an extension of current COVID-era tele-prescribing flexibilities for another year – through...more

Update: Federal and State Agencies Release Telehealth-Related Updates

Bradley Arant Boult Cummings LLP on 10/29/2024

Following the telehealth boom initiated by the COVID-19 pandemic, agencies continue to contend with competing interests in the telehealth space. Current legislation on both state and federal levels indicates that while these...more

Pending DEA Extension on Prescription of Controlled Substances via Telemedicine

McDermott+ on 10/14/2024

A new rule posted on the Office of Management and Budget (OMB) registry suggests that the Drug Enforcement Administration (DEA) is planning an additional extension of COVID-19 flexibilities for telemedicine prescribing of...more

CMS Proposes Extending COVID-Era Telehealth and Supervision Flexibilities through CY 2025

Baker Donelson on 7/30/2024

The Centers for Medicare & Medicaid Services (CMS) proposed to extend a number of COVID-era regulatory flexibilities related to telehealth, remote services, and supervision in the CY 2025 Medicare Physician Fee Schedule (PFS)...more

Healthcare Execs Face Federal Drug Charges in Landmark Telehealth Case

Bradley Arant Boult Cummings LLP on 7/3/2024

In a first-of-its-kind prosecution, federal prosecutors have charged two healthcare executives with unlawfully distributing controlled substances, such as Adderall, through a telehealth website. These charges demonstrate...more

This Week From the Hill (June 16 – 22, 2024)

Groom Law Group, Chartered on 6/18/2024

Each week while Congress is in session, our Policy team delivers a key update to highlight a topical benefits, health, or retirement news item from the Hill, such as a newly introduced bill, a summary of a committee hearing,...more

Exploring the Virtual Care Policy Landscape One Year Post-PHE

McDermott+ on 5/15/2024

May 11, 2024, marked one year since the end of the COVID-19 public health emergency (PHE), and not much has changed in Medicare telehealth policy. We are still operating under temporary waivers and flexibilities and, as a...more

2024: The Year of the Telehealth Cliff

McDermott Will & Schulte on 1/15/2024

What does December 31, 2024, mean to you? New Year’s Eve? Post-2024 election? Too far away to know? Our answer: December 31, 2024, is when we will go over a “telehealth cliff” if Congress fails to act before that date,...more

Looking Forward: Top Policy Areas for 2024

McDermott+ on 1/4/2024

Happy New Year! As we enter 2024, we want to lay out some of the main regulatory issues (both new and old) that McDermott+Consulting will be tracking over the next year. While these may evolve, we think they are still...more

Podcast: Telehealth Post-Public Health Emergency – What to Expect in 2024 – Diagnosing Health Care

Epstein Becker & Green on 12/7/2023

What trends in state laws and regulations have emerged in the post-public health emergency (PHE) era, and how do these changes impact telehealth stakeholders? At the federal level, many telehealth-related flexibilities have...more

395 Results

View per page

Page: of 16

Coronavirus/COVID-19 › Telehealth › Telemedicine

"My best business intelligence, in one easy email…"